Mesalamine Drugs
Links shared publicly online about this topic
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
drugs.com — “Lialda (mesalamine) is used to treat ulcerative colitis. Information from Drugs.com includes Lialda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 1:07 am By:
Drugs and Devices OW OW Health
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis: Lialda has be... http://bit.ly/pKdIFe #drug
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
drugs.com — “Lialda (mesalamine) is used to treat ulcerative colitis. Information from Drugs.com includes Lialda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 12:41 am By:
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis - http://bit.ly/rbWZJQ
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Rele” View full resource at medicalnewstoday.com
Most Recently Shared on July 18, 2011 at 4:05 pm By:
MNT Drug Approvals Health News
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YkK #regulatory
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP; NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Ta” View full resource at medicalnewstoday.com
Most Recently Shared on July 20, 2011 at 9:07 am By:
MNT Drug Approvals Health News
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YpB #regulatory
Pentasa Pill Identifiers: Pill identifiers, or drug identifiers, are tools used to identify Pentasa (mesalamine) or... http://bit.ly/5IdGp7
bit.ly — “Pentasa Pill Identifiers: Pill identifiers, or drug identifiers, are tools used to identify Pentasa (mesalamine) or... http://bit.ly/5IdGp7” View full resource at bit.ly
Most Recently Shared on December 17, 2009 at 6:35 pm By:
Inflammatory Bowel Syndrome OW Health
Pentasa Pill Identifiers: Pill identifiers, or drug identifiers, are tools used to identify Pentasa (mesalamine) or... http://bit.ly/5IdGp7
A Novel Oral Drug For The Treatment Of Moderate To Severe Crohn's Disease Would Earn 40 Percent Patient Share In The U.S. And Europe
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that for the treatment of Crohn's disease, a novel oral drug for the trea” View full resource at medicalnewstoday.com
Most Recently Shared on April 15, 2010 at 3:14 pm By:
A Novel Oral Drug For The Treatment Of Moderate To Severe Crohn's Disease Would Earn 40 Percent Patient Share In The U... http://mnt.to/3BgD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
